Healthcare DIVE May 16, 2017
Meg Bryant

Dive Brief:

  • The shift to value-based care will transform healthcare companies’ business strategies in the coming years, a new Lazard survey of global industry leaders suggests.
  • Adoption of value-based or risk-sharing pricing models will be disruptive over the next five to 10 years, according to 47% of the surveyed C-suite executives and investors in the U.S. and European pharma/biotech, medical devices/technology and healthcare services sectors.
  • In the U.S., respondents expected little slowdown under the President Donald Trump administration — with more than half (55%) predicting a majority of U.S. healthcare payments being value-based by 2020.

Dive Insight:

With the rapidly changing healthcare environment, many organizations in the industry are looking to partner with entities rather than purchase them...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ACO (Accountable Care), CMS, Health System / Hospital, MACRA, Market Research, Medicaid, Medicare, Patient / Consumer, Payer, Physician, Population Health Mgmt, Primary care, Provider, RCM (Revenue Cycle Mgmt), Value Based
AHA releases 2025-2027 Strategic Plan
Navigating the world of artificial intelligence in health care
Blue Shield of California appoints first female CEO
Health System Leader Expectations
Access to care: Five principles for action on primary health-care teams

Share This Article